57.93USD-0.65%Mkt Cap: 10.40B $P/E: —1d ago
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory dia…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Pricier
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap10.40B $
Enterprise Value11.08B $
Revenue (TTM)1.36B $
Gross Profit797.90M $
Net Income (TTM)-245.03M $
Revenue/Share7.735 USD
Last Price57.93 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.8K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-543.08
PEG—
EV/EBITDA-59.82
EV/Revenue8.12
P/S7.63
P/B24.94
EPS (TTM)-1.72
EPS (Forward)-0.11
52W Range
41.7326% of range104.32
52W High104.32 USD
52W Low41.73 USD
Profitability
Gross Margin62.74%
Oper. Margin-24.33%
EBITDA Margin-13.58%
Profit Margin-19.27%
ROE-49.87%
ROA-10.77%
Growth
Revenue Growth36.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-218.09M $
CapEx (TTM)27.27M $
FCF Margin-4.09%
FCF Yield-0.54%
Net Debt679.46M $
Net Debt/EBITDA-3.67
Balance Sheet
Debt/Equity2.70
Current Ratio3.31
Quick Ratio2.99
Book Value/Sh2.323 USD
Cash/Share3.559 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)66.53 USD
Upside (mean)+14.9%
Target Range35.00 USD – 100.00 USD
$35.00+14.9% to mean$100.00
# Analysts15
Ownership
Shares Out.174.52M
Float114.08M
Insiders37.12%
Institutions57.02%
Short Interest
Short Ratio5.4d
Short % Float38.44%
Short % Out.21.20%
Shares Short38.06M
Short (prev mo.)35.17M
Technical
SMA 5050.42 (+14.9%)
SMA 20063.49 (-8.8%)
Beta3.62
S&P 52W Chg20.05%
Avg Vol (30d)6.55M
Avg Vol (10d)7.39M
Technical Indicators
RSI (14)62.7
MACD1.8476
MACD Signal0.8475
MACD Hist.+1.0002
BB Upper57.84 USD
BB Middle50.92 USD
BB Lower44.01 USD
BB Width27.16%
ATR (14)3.719 USD
Vol Ratio (20d)0.66x